Global initiative to scale advanced therapeutic treatments to accelerate patient access worldwide. TUCSON, Ariz. and AMSTERDAM, March 26, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) today ...
Hundreds of therapeutics are in preclinical or clinical development for treating COVID-19 patients. But as of May 2020, so far none have demonstrated effectiveness sufficient to warrant approval for ...
TUCSON, Ariz., and AMSTERDAM March 26, 2026 — Critical Path Institute® (C-Path) today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative to enable scalable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results